The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCELLERA BIOLOGICS | COM | 00288U106 | 9,707,000 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
ADC THERAPEUTICS | SHS | H0036K147 | 10,743,188 | 6,471,800 | SH | SOLE | 6,471,800 | 0 | 0 | ||
ALKERMES | SHS | G01767105 | 416,100 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
BARRETT BUSINESS SERVICES | COM | 068463108 | 1,505,400 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 13,371,130 | 2,232,242 | SH | SOLE | 2,232,242 | 0 | 0 | ||
BIOMEA FUSION | COM | 09077A106 | 624,229 | 42,991 | SH | SOLE | 42,991 | 0 | 0 | ||
DESIGN THERAPEUTICS | COM | 25056L103 | 742,000 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
DEXCOM | COM | 252131107 | 2,854,070 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
ERASCA | COM | 29479A108 | 1,276,846 | 599,458 | SH | SOLE | 599,458 | 0 | 0 | ||
GALAPAGOS ADR REP | SPON ADR | 36315X101 | 33,629,501 | 827,294 | SH | SOLE | 827,294 | 0 | 0 | ||
GALAPAGOS ADR REP | CALL | 36315X901 | 4,878,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
GRAPHITE BIO | COM | 38870X104 | 3,542,080 | 1,351,939 | SH | SOLE | 1,351,939 | 0 | 0 | ||
KEZAR LIFE SCIENCES | COM | 49372L100 | 3,188,316 | 3,365,333 | SH | SOLE | 3,365,333 | 0 | 0 | ||
KURA ONCOLOGY | COM | 50127T109 | 13,661,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
MEDTRONIC | SHS | G5960L103 | 18,123,600 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
MEIRAGTX HOLDINGS | COM | G59665102 | 28,436,012 | 4,050,714 | SH | SOLE | 4,050,714 | 0 | 0 | ||
MIRUM PHARMACEUTICALS | COM | 604749101 | 8,658,246 | 293,301 | SH | SOLE | 293,301 | 0 | 0 | ||
MURAL ONCOLOGY | ORD SHS | G63365103 | 2,477,550 | 418,505 | SH | SOLE | 418,505 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES | COM | 64125C109 | 4,730,184 | 35,900 | SH | SOLE | 35,900 | 0 | 0 | ||
NUVATION BIO CL A | COM CL A | 67080N101 | 3,095,500 | 2,050,000 | SH | SOLE | 2,050,000 | 0 | 0 | ||
OPTION CARE HEALTH | COM NEW | 68404L201 | 5,013,072 | 148,800 | SH | SOLE | 148,800 | 0 | 0 | ||
ORIC PHARMACEUTICALS | COM | 68622P109 | 14,520,020 | 1,578,263 | SH | SOLE | 1,578,263 | 0 | 0 | ||
ORIC PHARMACEUTICALS | CALL | 68622P909 | 1,840,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ORTHOPEDIATRICS | COM | 68752L100 | 3,088,450 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
PACIRA BIOSCIENCES | COM | 695127100 | 8,719,226 | 258,424 | SH | SOLE | 258,424 | 0 | 0 | ||
PRIVIA HEALTH GROUP | COM | 74276R102 | 3,043,599 | 132,158 | SH | SOLE | 132,158 | 0 | 0 | ||
PROTHENA | CALL | G72800908 | 1,817,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTHENA | SHS | G72800108 | 8,341,447 | 229,539 | SH | SOLE | 229,539 | 0 | 0 | ||
PROTHENA | CALL | G72800908 | 127,190 | 3,500 | SH | SOLE | 3,500 | 0 | 0 | ||
QUIDELORTHO | COM | 219798105 | 8,764,404 | 118,920 | SH | SOLE | 118,920 | 0 | 0 | ||
SHATTUCK LABS | COM | 82024L103 | 19,841,343 | 2,782,797 | SH | SOLE | 2,782,797 | 0 | 0 | ||
SHOCKWAVE MEDICAL | COM | 82489T104 | 952,800 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
SPYRE THERAPEUTICS | COM NEW | 00773J202 | 1,183,600 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
UNIVERSAL HEALTH SERVICES CL B | CL B | 913903100 | 4,282,040 | 28,090 | SH | SOLE | 28,090 | 0 | 0 | ||
VERADIGM | COM | 01988P108 | 1,888,200 | 180,000 | SH | SOLE | 180,000 | 0 | 0 |